Beta-funaltrexamine disrupts the day-night rhythm of nociception in mice

Brain Res Bull. 1989 May;22(5):783-5. doi: 10.1016/0361-9230(89)90020-8.

Abstract

Determinations were made of the effects of beta-funaltrexamine (beta-FNA), an irreversible mu-opioid receptor antagonist, on the day-night rhythm of nociception in male mice. Peripheral administration of beta-FNA (20 and 40 mg/kg) disrupted the day-night rhythm of foot-licking response to aversive thermal (50 degrees C) stimulation. The peak nocturnal response latency was attenuated and the marked increases and decreases in response latency present at the light-dark and dark-light transitions, respectively, were suppressed. These results suggest that mu opioids are associated with the generation and expression of the day-night rhythm of this particular measure of nociception in mice.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Circadian Rhythm / drug effects*
  • Male
  • Mice
  • Naltrexone / analogs & derivatives*
  • Naltrexone / pharmacology
  • Narcotic Antagonists
  • Nociceptors / drug effects
  • Nociceptors / physiology*
  • Pain / physiopathology*
  • Receptors, Opioid / drug effects
  • Receptors, Opioid / physiology*
  • Receptors, Opioid, mu

Substances

  • Narcotic Antagonists
  • Receptors, Opioid
  • Receptors, Opioid, mu
  • Naltrexone
  • beta-funaltrexamine